Trademark: 97171522
Word
ZOAVE
Status
Pending
Status Code
732
Status Date
Tuesday, February 27, 2024
Serial Number
97171522
Mark Type
4000
Filing Date
Tuesday, December 14, 2021
Published for Opposition
Tuesday, July 5, 2022

Trademark Owner History
TEVA PHARMACEUTICALS USA, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the following systems and organs: autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, integumentary system diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, contraception, drug dependence, fertility disorders, hormone replacement, infectious diseases due to bacteria, viruses, fungi, parasites, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

Trademark Events
Feb 28, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 27, 2024
Sou Extension 3 Granted
Feb 27, 2024
Sou Extension 3 Filed
Feb 27, 2024
Sou Teas Extension Received
Aug 18, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 16, 2023
Sou Extension 2 Granted
Aug 16, 2023
Sou Extension 2 Filed
Aug 16, 2023
Sou Teas Extension Received
Feb 16, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 14, 2023
Sou Extension 1 Granted
Feb 14, 2023
Sou Extension 1 Filed
Feb 14, 2023
Sou Teas Extension Received
Aug 30, 2022
Noa E-Mailed - Sou Required From Applicant
Jul 5, 2022
Official Gazette Publication Confirmation E-Mailed
Jul 5, 2022
Published For Opposition
Jun 15, 2022
Notification Of Notice Of Publication E-Mailed
Jun 1, 2022
Approved For Pub - Principal Register
Jun 1, 2022
Examiner's Amendment Entered
Jun 1, 2022
Notification Of Examiners Amendment E-Mailed
Jun 1, 2022
Examiners Amendment E-Mailed
Jun 1, 2022
Examiners Amendment -Written
May 25, 2022
Assigned To Examiner
Dec 17, 2021
New Application Office Supplied Data Entered
Dec 17, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24